RenovoRx
RNXT
17 hedge funds and large institutions have $1.01M invested in RenovoRx in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
129% more capital invested
Capital invested by funds: $442K → $1.01M (+$570K)
70% more funds holding
Funds holding: 10 → 17 (+7)
0.65% more ownership
Funds ownership: 3.08% → 3.74% (+0.65%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$436K |
| 2 |
Millennium Management
New York
|
+$106K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$94.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$32.2K |
| 5 |
HF
HRT Financial
New York
|
+$14.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$14.3K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$92 |
RNXT Hedge Fund Activity: Q2 2024 in Review
17 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q2 2024, worth a combined $1.01M — up 129% from $442K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RNXT positions and 1 closed out — a net gain of 7 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $436K. The largest seller was BlackRock, cutting an estimated $14.3K.
- 17 institutional investors held RenovoRx (RNXT) as of Q2 2024, up from 10 in Q1 2024.
- Funds reported $1.01M of RenovoRx stock for Q2 2024, up 129% quarter-over-quarter.
- 8 funds opened new RenovoRx positions in Q2 2024 and 1 closed out, a net change of +7 holders.
- The largest RenovoRx buyer in Q2 2024 was ADAR1 Capital Management, an estimated $436K added.
- The largest RenovoRx seller in Q2 2024 was BlackRock, an estimated $14.3K sold.
Based on aggregated 13F filings for Q2 2024.